Persistent arterial wall inflammation in patients with elevated lipoprotein(a) despite strong low-density lipoprotein cholesterol reduction by proprotein convertase subtilisin/kexin type 9 antibody treatment - Stiekema, Lotte C A; Stroes, Erik S G; Verweij, Simone L; Kassahun, Helina; Chen, Lisa; Wasserman, Scott M; Sabatine, Marc S; Mani, Venkatesh; Fayad, Zahi A (European heart journal, 2019)
Keywords: Editor's Choice; Fast Track Clinical Research; Arterial wall inflammation; Lipoprotein(a); PCSK9 antibodies; Evolocumab; Atherosclerosis